CVS Health (CVS) cuts full-year profit outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
February 7, 2024 6:33 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of at least $8.30, versus... More
